| KCNN4 | potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4 | 19q13.2 | 0.257 | -0.347 | 2.02e-13
|
| RILP | Rab interacting lysosomal protein | 17p13.3 | 0.256 | -0.32 | 1.55e-11
|
| TRAPPC2B | trafficking protein particle complex 2B | 19q13.43 | 0.253 | -0.301 | 2.84e-10
|
| WDPCP | WD repeat containing planar cell polarity effector | 2p15 | 0.252 | 0.314 | 4.1e-11
|
| UQCR11 | ubiquinol-cytochrome c reductase, complex III subunit XI | 19p13.3 | 0.252 | -0.377 | 5.39e-16
|
| MIB1 | mindbomb E3 ubiquitin protein ligase 1 | 18q11.2 | 0.248 | 0.431 | 0
|
| GIPC1 | GIPC PDZ domain containing family, member 1 | 19p13.1 | 0.248 | -0.389 | 0
|
| DTX2 | deltex 2, E3 ubiquitin ligase | 7q11.23 | 0.248 | -0.27 | 1.75e-08
|
| CIB1 | calcium and integrin binding 1 (calmyrin) | 15q25.3-q26 | 0.245 | -0.492 | 0
|
| FAM98C | family with sequence similarity 98, member C | 19q13.2 | 0.245 | -0.36 | 2.11e-14
|
| DNA2 | DNA replication helicase/nuclease 2 | 10q21.3-q22.1 | 0.244 | 0.416 | 0
|
| TNFRSF14 | tumor necrosis factor receptor superfamily, member 14 | 1p36.32 | 0.242 | -0.371 | 2.23e-15
|
| NRAS | neuroblastoma RAS viral (v-ras) oncogene homolog | 1p13.2 | 0.24 | 0.298 | 4.16e-10
|
| FAM234A | family with sequence similarity 234, member A | 16p13.3 | 0.239 | -0.156 | 0.00125
|
| PSMB10 | proteasome subunit beta 10 | 16q22.1 | 0.239 | -0.364 | 1.06e-14
|
| TMPRSS4 | transmembrane protease, serine 4 | 11q23.3 | 0.239 | -0.334 | 1.93e-12
|
| GALE | UDP-galactose-4-epimerase | 1p36-p35 | 0.239 | -0.351 | 9.97e-14
|
| EPB41L5 | erythrocyte membrane protein band 4.1 like 5 | 2q14.2 | 0.238 | 0.349 | 1.61e-13
|
| GPR161 | G protein-coupled receptor 161 | 1q23.3 | 0.238 | 0.359 | 2.69e-14
|
| TMEFF1 | transmembrane protein with EGF-like and two follistatin-like domains 1 | 9q31 | 0.237 | 0.432 | 0
|
| ANKRD26 | ankyrin repeat domain 26 | 10p12.1 | 0.237 | 0.411 | 0
|
| SDCBP2 | syndecan binding protein (syntenin) 2 | 20p13 | 0.236 | -0.425 | 0
|
| RER1 | retention in endoplasmic reticulum sorting receptor 1 | 1p36 | 0.234 | -0.377 | 6.46e-16
|
| SH3BGRL3 | SH3 domain binding glutamate-rich protein like 3 | 1p36.11 | 0.234 | -0.388 | 0
|
| NUP160 | nucleoporin 160kDa | 11p11.12 | 0.234 | 0.449 | 0
|
| CKAP5 | cytoskeleton associated protein 5 | 11p11.2 | 0.234 | 0.421 | 0
|
| POLR3A | polymerase (RNA) III (DNA directed) polypeptide A, 155kDa | 10q22.3 | 0.234 | 0.382 | 1.33e-16
|
| ERC1 | ELKS/RAB6-interacting/CAST family member 1 | 12p13.3 | 0.233 | 0.316 | 3.05e-11
|
| TCIRG1 | T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 | 11q13.2 | 0.231 | -0.419 | 0
|
| MIR22HG | MIR22 host gene | 17p13.3 | 0.231 | -0.34 | 6.46e-13
|
| SEMA4B | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B | 15q25 | 0.23 | -0.266 | 2.71e-08
|
| VASH2 | vasohibin 2 | 1q23 | 0.23 | 0.309 | 7.92e-11
|
| CAPNS1 | calpain, small subunit 1 | 19q13.1 | 0.23 | -0.345 | 3.11e-13
|
| LDLRAD3 | low density lipoprotein receptor class A domain containing 3 | 11p13 | 0.229 | 0.344 | 3.47e-13
|
| GNA15 | guanine nucleotide binding protein (G protein), alpha 15 (Gq class) | 19p13.3 | 0.229 | -0.415 | 0
|
| SEPW1 | selenoprotein W, 1 | 19q13.33 | 0.228 | -0.365 | 8.34e-15
|
| MMP28 | matrix metallopeptidase 28 | 17q12 | 0.227 | -0.401 | 0
|
| IFT81 | intraflagellar transport 81 | 12q24.13 | 0.227 | 0.28 | 4.39e-09
|
| ZNF496 | zinc finger protein 496 | 1q44 | 0.226 | 0.365 | 7.71e-15
|
| PLEKHM1 | pleckstrin homology domain containing, family M (with RUN domain) member 1 | 17q21.31 | 0.225 | -0.31 | 6.81e-11
|
| PROM2 | prominin 2 | 2q11.1 | 0.222 | -0.297 | 4.79e-10
|
| ZBTB7A | zinc finger and BTB domain containing 7A | 19p13.3 | 0.222 | -0.354 | 6.08e-14
|
| PYGO1 | pygopus family PHD finger 1 | 15q21.1 | 0.221 | 0.319 | 1.9e-11
|
| ZNF391 | zinc finger protein 391 | 6p21 | 0.221 | 0.396 | 0
|
| HAGH | hydroxyacylglutathione hydrolase | 16p13.3 | 0.221 | -0.29 | 1.23e-09
|
| MYH10 | myosin, heavy chain 10, non-muscle | 17p13 | 0.22 | 0.449 | 0
|
| ZCCHC18 | zinc finger, CCHC domain containing 18 | Xq22.2 | 0.22 | 0.152 | 0.00164
|
| ALS2CL | ALS2 C-terminal like | 3p21.31 | 0.22 | -0.275 | 9.07e-09
|
| LGSN | lengsin, lens protein with glutamine synthetase domain | 6q12 | 0.219 | 0.235 | 9.75e-07
|
| VASP | vasodilator-stimulated phosphoprotein | 19q13.32 | 0.219 | -0.347 | 2.2e-13
|
| NR1H2 | nuclear receptor subfamily 1, group H, member 2 | 19q13.3 | 0.219 | -0.377 | 5.76e-16
|
| FXYD3 | FXYD domain containing ion transport regulator 3 | 19q13.12 | 0.219 | -0.38 | 2.6e-16
|
| RHBDF1 | rhomboid 5 homolog 1 (Drosophila) | 16p13.3 | 0.219 | -0.299 | 3.67e-10
|
| C1orf112 | chromosome 1 open reading frame 112 | 1q24.2 | 0.219 | 0.302 | 2.36e-10
|
| SLC25A53 | solute carrier family 25, member 53 | Xq22.2 | 0.216 | 0.247 | 2.72e-07
|
| AS3MT | arsenite methyltransferase | 10q24.33 | 0.216 | 0.351 | 1.18e-13
|
| PCED1B | PC-esterase domain containing 1B | 12q13.11 | 0.216 | -0.312 | 5.83e-11
|
| NDUFB4 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 4, 15kDa | 3q13.33 | 0.216 | -0.214 | 8.65e-06
|
| EXTL2 | exostosin-like glycosyltransferase 2 | 1p21 | 0.216 | 0.284 | 2.59e-09
|
| CCDC96 | coiled-coil domain containing 96 | 4p16.1 | 0.216 | -0.309 | 8.9e-11
|
| ZBED3 | zinc finger, BED-type containing 3 | 5q13.2 | 0.216 | 0.369 | 3.92e-15
|
| SCN8A | sodium channel, voltage gated, type VIII alpha subunit | 12q13.1 | 0.216 | 0.231 | 1.55e-06
|
| SPOCD1 | SPOC domain containing 1 | 1p35.1 | 0.215 | -0.364 | 9.93e-15
|
| EFHD2 | EF-hand domain family, member D2 | 1p36 | 0.215 | -0.388 | 0
|
| CYB561D2 | cytochrome b561 family, member D2 | 3p21.3 | 0.215 | -0.314 | 3.78e-11
|
| MOB3C | MOB kinase activator 3C | 1p34.1 | 0.215 | -0.375 | 9.11e-16
|
| ACAA2 | acetyl-CoA acyltransferase 2 | 18q21 | 0.215 | 0.318 | 2.1e-11
|
| GPR39 | G protein-coupled receptor 39 | 2q21-q22 | 0.215 | -0.227 | 2.19e-06
|
| GSTK1 | glutathione S-transferase kappa 1 | 7q34 | 0.215 | -0.386 | 5e-18
|
| B3GALT4 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 | 6p21.3 | 0.214 | -0.409 | 0
|
| ZG16B | zymogen granule protein 16B | 16p13.3 | 0.214 | -0.318 | 2.08e-11
|
| ZNRF3 | zinc and ring finger 3 | 22q12.1 | 0.214 | 0.379 | 3.83e-16
|
| DZIP1 | DAZ interacting zinc finger protein 1 | 13q32.1 | 0.213 | 0.312 | 5.3e-11
|
| RAB30 | RAB30, member RAS oncogene family | 11q14.1 | 0.213 | 0.248 | 2.35e-07
|
| MINOS1 | mitochondrial inner membrane organizing system 1 | 1p36.13 | 0.213 | -0.358 | 2.91e-14
|
| CDC42EP5 | CDC42 effector protein (Rho GTPase binding) 5 | 19q13.42 | 0.213 | -0.314 | 3.84e-11
|
| TMEM51 | transmembrane protein 51 | 1p36.21 | 0.213 | -0.4 | 0
|
| TAX1BP3 | Tax1 (human T-cell leukemia virus type I) binding protein 3 | 17p13 | 0.213 | -0.264 | 3.65e-08
|
| ZYG11A | zyg-11 family member A, cell cycle regulator | 1p32.3 | 0.212 | 0.246 | 2.75e-07
|
| SOGA1 | suppressor of glucose, autophagy associated 1 | 20q11.23 | 0.212 | 0.333 | 2.17e-12
|
| BCORL1 | BCL6 corepressor-like 1 | Xq25-q26.1 | 0.212 | 0.422 | 0
|
| GPR108 | G protein-coupled receptor 108 | 19p13.3 | 0.212 | -0.379 | 3.48e-16
|
| MEX3B | mex-3 RNA binding family member B | 15q25.1 | 0.212 | 0.319 | 2e-11
|
| RAPGEF3 | Rap guanine nucleotide exchange factor (GEF) 3 | 12q13.1 | 0.212 | -0.326 | 6.87e-12
|
| RFX3 | regulatory factor X, 3 (influences HLA class II expression) | 9p24.2 | 0.212 | 0.351 | 1.01e-13
|
| TMEM169 | transmembrane protein 169 | 2q35 | 0.212 | 0.309 | 8.77e-11
|
| LOC115110 | | | 0.212 | -0.312 | 5.27e-11
|
| CBX7 | chromobox homolog 7 | 22q13.1 | 0.211 | -0.287 | 1.89e-09
|
| REEP5 | receptor accessory protein 5 | 5q22-q23 | 0.211 | -0.327 | 5.53e-12
|
| WHAMM | WAS protein homolog associated with actin, golgi membranes and microtubules | 15q25.2 | 0.211 | -0.235 | 1.01e-06
|
| IL4R | interleukin 4 receptor | 16p12.1-p11.2 | 0.21 | -0.263 | 3.95e-08
|
| HDAC7 | histone deacetylase 7 | 12q13.1 | 0.209 | -0.278 | 6.31e-09
|
| SRPX2 | sushi-repeat containing protein, X-linked 2 | Xq22.1 | 0.208 | -0.354 | 6.81e-14
|
| ZRANB1 | zinc finger, RAN-binding domain containing 1 | 10q26.12 | 0.208 | 0.295 | 6.39e-10
|
| NACAD | NAC alpha domain containing | 7p13 | 0.208 | 0.19 | 7.7e-05
|
| WASF1 | WAS protein family, member 1 | 6q21 | 0.208 | 0.272 | 1.23e-08
|
| GPR173 | G protein-coupled receptor 173 | Xp11 | 0.208 | 0.261 | 4.99e-08
|
| EPHB6 | EPH receptor B6 | 7q33-q35 | 0.208 | -0.335 | 1.52e-12
|
| PTGES | prostaglandin E synthase | 9q34.3 | 0.207 | -0.275 | 9.02e-09
|
| CD63 | CD63 molecule | 12q12-q13 | 0.207 | -0.283 | 3e-09
|
| GPRC5B | G protein-coupled receptor, class C, group 5, member B | 16p12 | 0.207 | 0.25 | 1.77e-07
|
| CAMK4 | calcium/calmodulin-dependent protein kinase IV | 5q22.1 | 0.207 | 0.1 | 0.0394
|
| DAPP1 | dual adaptor of phosphotyrosine and 3-phosphoinositides | 4q25-q27 | 0.206 | -0.165 | 0.000635
|
| SDC4 | syndecan 4 | 20q12 | 0.206 | -0.318 | 2.1e-11
|
| AMDHD2 | amidohydrolase domain containing 2 | 16p13.3 | 0.206 | -0.245 | 3.1e-07
|
| CBX1 | chromobox homolog 1 | 17q21.32 | 0.206 | 0.37 | 3.08e-15
|
| NINL | ninein-like | 20p11.22-p11.1 | 0.205 | 0.329 | 4.06e-12
|
| AMY2B | amylase, alpha 2B (pancreatic) | 1p21 | 0.205 | -0.341 | 6.26e-13
|
| BMPR1A | bone morphogenetic protein receptor, type IA | 10q22.3 | 0.205 | 0.313 | 4.49e-11
|
| ZNF462 | zinc finger protein 462 | 9q31.3 | 0.205 | 0.315 | 3.26e-11
|
| HOXD10 | homeobox D10 | 2q31.1 | 0.204 | 0.082 | 0.0913
|
| ALPK1 | alpha-kinase 1 | 4q26 | 0.204 | -0.12 | 0.0132
|
| ARSK | arylsulfatase family, member K | 5q15 | 0.204 | 0.328 | 4.66e-12
|
| CATSPER1 | cation channel, sperm associated 1 | 11q12.1 | 0.203 | -0.27 | 1.65e-08
|
| PINK1 | PTEN induced putative kinase 1 | 1p36.12 | 0.203 | -0.276 | 7.28e-09
|
| RPS6KA1 | ribosomal protein S6 kinase, 90kDa, polypeptide 1 | 1p | 0.203 | -0.228 | 2.17e-06
|
| CHML | choroideremia-like (Rab escort protein 2) | 1q43 | 0.202 | 0.378 | 4.62e-16
|
| DHRS3 | dehydrogenase/reductase (SDR family) member 3 | 1p36.1 | 0.202 | -0.314 | 4.09e-11
|
| CASC15 | cancer susceptibility candidate 15 (non-protein coding) | 6p22.3 | 0.202 | 0.249 | 2.09e-07
|
| TBC1D2 | TBC1 domain family, member 2 | 9q22.32 | 0.202 | -0.19 | 8.33e-05
|
| HMOX2 | heme oxygenase 2 | 16p13.3 | 0.201 | -0.362 | 1.54e-14
|
| MYO1C | myosin IC | 17p13.3 | 0.201 | -0.154 | 0.00142
|
| SV2A | synaptic vesicle glycoprotein 2A | 1q21.2 | 0.201 | 0.281 | 3.93e-09
|
| IL17RD | interleukin 17 receptor D | 3p21.1 | 0.201 | 0.367 | 5.26e-15
|
| CCL17 | chemokine (C-C motif) ligand 17 | 16q13 | 0.2 | -0.377 | 5.1e-16
|
| TADA2B | transcriptional adaptor 2B | 4p16.1 | 0.2 | -0.251 | 1.58e-07
|
| GPX7 | glutathione peroxidase 7 | 1p32 | 0.2 | 0.302 | 2.41e-10
|
| HSF2 | heat shock transcription factor 2 | 6q22 | 0.2 | 0.352 | 9.83e-14
|
| TRIM31 | tripartite motif containing 31 | 6p21.3 | 0.2 | -0.318 | 2.29e-11
|
| HOXB2 | homeobox B2 | 17q21.32 | 0.199 | -0.173 | 0.000335
|
| HNRNPH3 | heterogeneous nuclear ribonucleoprotein H3 (2H9) | 10q22 | 0.199 | 0.349 | 1.67e-13
|
| NUBP1 | nucleotide binding protein 1 | 16p13.13 | 0.199 | -0.285 | 2.49e-09
|
| STK33 | serine/threonine kinase 33 | 11p15.3 | 0.199 | 0.26 | 5.55e-08
|
| VILL | villin-like | 3p21 | 0.198 | -0.319 | 1.87e-11
|
| ETHE1 | ethylmalonic encephalopathy 1 | 19q13.32 | 0.198 | -0.313 | 5e-11
|
| TAF5 | TAF5 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 100kDa | 10q24-q25.2 | 0.198 | 0.256 | 9.13e-08
|
| TULP3 | tubby like protein 3 | 12p13 | 0.197 | 0.378 | 4.76e-16
|
| EIF6 | eukaryotic translation initiation factor 6 | 20q11.2 | 0.197 | -0.37 | 3.14e-15
|
| SMO | smoothened, frizzled class receptor | 7q32.1 | 0.197 | 0.367 | 5.79e-15
|
| RASSF5 | Ras association (RalGDS/AF-6) domain family member 5 | 1q31 | 0.197 | -0.3 | 2.86e-10
|
| SOSTDC1 | sclerostin domain containing 1 | 7p21.2 | 0.196 | 0.236 | 8.98e-07
|
| DBN1 | drebrin 1 | 5q35.3 | 0.196 | 0.293 | 8.09e-10
|
| PPM1F | protein phosphatase, Mg2+/Mn2+ dependent, 1F | 22q11.22 | 0.196 | -0.066 | 0.173
|
| WDR1 | WD repeat domain 1 | 4p16.1 | 0.196 | -0.288 | 1.66e-09
|
| MISP | mitotic spindle positioning | 19p13.3 | 0.196 | -0.276 | 7.23e-09
|
| MYO3A | myosin IIIA | 10p11.1 | 0.196 | 0.071 | 0.141
|
| ST7L | suppression of tumorigenicity 7 like | 1p13.1 | 0.195 | 0.005 | 0.916
|
| LIN28B | lin-28 homolog B (C. elegans) | 6q21 | 0.195 | 0.25 | 1.9e-07
|
| MROH6 | maestro heat-like repeat family member 6 | 8q24.3 | 0.195 | -0.176 | 0.000264
|
| SRSF12 | serine/arginine-rich splicing factor 12 | 6q16.1 | 0.195 | 0.276 | 8e-09
|
| SUSD5 | sushi domain containing 5 | 3p23 | 0.195 | 0.041 | 0.393
|
| PCCB | propionyl CoA carboxylase, beta polypeptide | 3q21-q22 | 0.194 | -0.113 | 0.0192
|
| KCTD7 | potassium channel tetramerization domain containing 7 | 7q11.21 | 0.194 | 0.335 | 1.67e-12
|
| PRDM11 | PR domain containing 11 | 11p11 | 0.194 | 0.175 | 0.000277
|
| CCDC117 | coiled-coil domain containing 117 | 22q12.1 | 0.194 | 0.312 | 5.7e-11
|
| ESYT3 | extended synaptotagmin-like protein 3 | 3q22.3 | 0.194 | 0.331 | 2.84e-12
|
| TCEAL5 | transcription elongation factor A (SII)-like 5 | Xq22.2 | 0.193 | 0.145 | 0.00277
|
| ZNF660 | zinc finger protein 660 | 3p21.32 | 0.193 | 0.299 | 3.36e-10
|
| MAGEE1 | melanoma antigen family E1 | Xq13 | 0.192 | 0.268 | 2.14e-08
|
| GFRA3 | GDNF family receptor alpha 3 | 5q31.1-q31.3 | 0.192 | 0.239 | 6.36e-07
|
| MAP2K3 | mitogen-activated protein kinase kinase 3 | 17q11.2 | 0.192 | -0.381 | 1.85e-16
|
| TMEM127 | transmembrane protein 127 | 2q11.2 | 0.192 | -0.113 | 0.0196
|
| FBN2 | fibrillin 2 | 5q23-q31 | 0.192 | 0.237 | 7.7e-07
|
| NDFIP1 | Nedd4 family interacting protein 1 | 5q31.3 | 0.192 | -0.269 | 1.87e-08
|
| LGALS9C | lectin, galactoside-binding, soluble, 9C | 17p11.2 | 0.191 | -0.272 | 1.26e-08
|
| CYSRT1 | cysteine-rich tail protein 1 | 9q34.3 | 0.191 | -0.299 | 3.53e-10
|
| KIAA1919 | KIAA1919 | 6q22 | 0.191 | 0.287 | 1.94e-09
|
| TBC1D2B | TBC1 domain family, member 2B | 15q24.3-q25.1 | 0.189 | -0.082 | 0.0901
|
| METTL10 | methyltransferase like 10 | 10q26.13 | 0.188 | 0.276 | 7.22e-09
|
| PLCG1 | phospholipase C, gamma 1 | 20q12-q13.1 | 0.187 | 0.344 | 3.64e-13
|
| RAB8A | RAB8A, member RAS oncogene family | 19p13.2-p13.1 | 0.187 | -0.207 | 1.69e-05
|
| FAM129B | family with sequence similarity 129, member B | 9q34.13 | 0.187 | -0.235 | 9.95e-07
|
| NRCAM | neuronal cell adhesion molecule | 7q31 | 0.187 | 0.201 | 2.94e-05
|
| TP73 | tumor protein p73 | 1p36.3 | 0.187 | 0.04 | 0.404
|
| PEG10 | paternally expressed 10 | 7q21 | 0.187 | 0.249 | 2.05e-07
|
| ABR | active BCR-related | 17p13 | 0.187 | -0.22 | 4.84e-06
|
| RAET1E | retinoic acid early transcript 1E | 6q24.3 | 0.186 | -0.309 | 8.74e-11
|
| DGKQ | diacylglycerol kinase, theta 110kDa | 4p16.3 | 0.186 | -0.335 | 1.53e-12
|
| PTH2R | parathyroid hormone 2 receptor | 2q33 | 0.186 | 0.181 | 0.000178
|
| CD58 | CD58 molecule | 1p13 | 0.185 | -0.28 | 4.65e-09
|
| ORAOV1 | oral cancer overexpressed 1 | 11q13.2 | 0.185 | -0.101 | 0.0379
|
| DIP2C | disco-interacting protein 2 homolog C | 10p15.3 | 0.185 | 0.237 | 8.17e-07
|
| MMAA | methylmalonic aciduria (cobalamin deficiency) cblA type | 4q31.1 | 0.184 | -0.22 | 4.49e-06
|
| LHFPL3-AS2 | LHFPL3 antisense RNA 2 | 7q22.3 | 0.184 | 0.129 | 0.00779
|
| CEP83-AS1 | CEP83 antisense RNA 1 (head to head) | 12q22 | 0.184 | 0.3 | 3.13e-10
|
| PHGDH | phosphoglycerate dehydrogenase | 1p12 | 0.183 | 0.311 | 6.57e-11
|
| LONRF3 | LON peptidase N-terminal domain and ring finger 3 | Xq24 | 0.183 | -0.18 | 0.000184
|
| CLUAP1 | clusterin associated protein 1 | 16p13.3 | 0.182 | 0.166 | 0.000577
|
| NRSN2 | neurensin 2 | 20p13 | 0.181 | 0.253 | 1.33e-07
|
| ANKRD36 | ankyrin repeat domain 36 | 2q11.2 | 0.181 | 0.286 | 2.07e-09
|
| SKIDA1 | SKI/DACH domain containing 1 | 10p12.31 | 0.181 | 0.257 | 8.33e-08
|
| ABCA7 | ATP-binding cassette, sub-family A (ABC1), member 7 | 19p13.3 | 0.18 | -0.273 | 1.2e-08
|
| C6orf132 | chromosome 6 open reading frame 132 | 6p21.1 | 0.18 | -0.231 | 1.47e-06
|
| DUSP5P1 | dual specificity phosphatase 5 pseudogene 1 | 1q42.13 | 0.18 | 0.216 | 6.86e-06
|
| TBC1D10A | TBC1 domain family, member 10A | 22q12.2 | 0.18 | -0.289 | 1.48e-09
|
| TMEM98 | transmembrane protein 98 | 17q11.2 | 0.18 | 0.178 | 0.000225
|
| PTPRH | protein tyrosine phosphatase, receptor type, H | 19q13.4 | 0.18 | -0.282 | 3.51e-09
|
| TPRG1L | tumor protein p63 regulated 1-like | 1p36.32 | 0.179 | -0.184 | 0.000137
|
| KAZALD1 | Kazal-type serine peptidase inhibitor domain 1 | 10q24.32 | 0.179 | 0.158 | 0.00104
|
| ATP2A3 | ATPase, Ca++ transporting, ubiquitous | 17p13.3 | 0.178 | -0.223 | 3.35e-06
|
| LRG1 | leucine-rich alpha-2-glycoprotein 1 | 19p13.3 | 0.178 | -0.271 | 1.53e-08
|
| ADAM15 | ADAM metallopeptidase domain 15 | 1q21.3 | 0.177 | -0.29 | 1.26e-09
|
| NPY4R | neuropeptide Y receptor Y4 | 10q11.2 | 0.175 | 0.055 | 0.259
|
| SQSTM1 | sequestosome 1 | 5q35 | 0.173 | -0.279 | 5.44e-09
|
| TCF3 | transcription factor 3 | 19p13.3 | 0.172 | 0.13 | 0.00717
|
| SUPT4H1 | SPT4 homolog, DSIF elongation factor subunit | 17q22 | 0.172 | -0.088 | 0.07
|
| ADRBK2 | adrenergic, beta, receptor kinase 2 | 22q11 | 0.171 | 0.153 | 0.0015
|
| DRAM2 | DNA-damage regulated autophagy modulator 2 | 1p13.3 | 0.17 | -0.226 | 2.44e-06
|
| C12orf76 | chromosome 12 open reading frame 76 | 12q24.11 | 0.17 | 0.124 | 0.0101
|
| VWA2 | von Willebrand factor A domain containing 2 | 10q25.3 | 0.168 | 0.156 | 0.00119
|
| C15orf52 | chromosome 15 open reading frame 52 | 15q15.1 | 0.167 | -0.218 | 5.97e-06
|
| CYP2B7P | cytochrome P450, family 2, subfamily B, polypeptide 7, pseudogene | 19q13.2 | 0.167 | -0.018 | 0.715
|
| MARCH3 | membrane-associated ring finger (C3HC4) 3, E3 ubiquitin protein ligase | 5q23.2 | 0.166 | -0.203 | 2.42e-05
|
| FAM35BP | family with sequence similarity 35, member B, pseudogene | 10q11.22 | 0.166 | 0.152 | 0.00169
|
| TYRO3 | TYRO3 protein tyrosine kinase | 15q15.1-q21.1 | 0.165 | 0.066 | 0.174
|
| ATG4A | autophagy related 4A, cysteine peptidase | Xq22.3 | 0.164 | -0.16 | 0.000894
|
| PCDHB17P | protocadherin beta 17 pseudogene | 5q31.3 | 0.162 | 0.249 | 1.97e-07
|
| HIST1H1D | histone cluster 1, H1d | 6p21.3 | 0.16 | 0.224 | 3.02e-06
|
| TLX1 | T-cell leukemia homeobox 1 | 10q24.32 | 0.157 | 0.124 | 0.0101
|
| C15orf27 | transmembrane protein 266 | 15q23-q24.1 | 0.157 | 0.065 | 0.18
|
| SS18 | synovial sarcoma translocation, chromosome 18 | 18q11.2 | 0.156 | 0.039 | 0.419
|
| ISM2 | isthmin 2 | 14q24.3 | 0.155 | 0.185 | 0.000129
|
| CAMKK1 | calcium/calmodulin-dependent protein kinase kinase 1, alpha | 17p13.3 | 0.136 | -0.162 | 0.000802
|